Skip to main content

Peer Review reports

From: Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease

Original Submission
3 Jul 2017 Submitted Original manuscript
11 Jul 2017 Reviewed Reviewer Report - Teresa Morán
23 Jul 2017 Reviewed Reviewer Report - Samantha Aso
19 Aug 2017 Author responded Author comments - Tatsuya Nitawaki
Resubmission - Version 2
19 Aug 2017 Submitted Manuscript version 2
24 Aug 2017 Reviewed Reviewer Report - Teresa Morán
6 Sep 2017 Reviewed Reviewer Report - Samantha Aso
7 Oct 2017 Author responded Author comments - Tatsuya Nitawaki
Resubmission - Version 3
7 Oct 2017 Submitted Manuscript version 3
13 Nov 2017 Author responded Author comments - Tatsuya Nitawaki
Resubmission - Version 4
13 Nov 2017 Submitted Manuscript version 4
Publishing
23 Nov 2017 Editorially accepted
6 Dec 2017 Article published 10.1186/s12890-017-0519-y

You can find further information about peer review here.

Back to article page